Mark A. Schlossberg is SVP and General Counsel at Impax Laboratories, LLC (IPXL). They have made 7 open-market trades across 2 companies since 2013, most recently 2022-03-15.
CIK 0001520533
1 open-market purchase totalling $17K since 2013, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CYTK | SELL | 2022-03-15 | 2022-03-15 | $33.96 | $1.7M | +6.7% | +15.8% | +15.0% |
| CYTK | SELL | 2021-10-19 | 2021-10-20 | $35.74 | $1.4M | -3.2% | +15.2% | -8.7% |
| CYTK | SELL | 2020-08-21 | 2020-08-21 | $25.00 | $250K | +2.8% | -11.6% | -34.2% |
| CYTK | SELL | 2020-07-29 | 2020-07-30 | $23.07 | $231K | -6.7% | +6.0% | -32.1% |
| IPXL | SELL | 2015-09-11 | 2015-09-14 | $43.30 | $323K | -14.0% | +0.8% | +0.8% |
| IPXL | SELL | 2015-08-27 | 2015-08-27 | $43.41 | $202K | -14.0% | +0.8% | +0.8% |
| IPXL | BUY | 2013-03-12 | 2013-03-14 | $16.73 | $17K | -14.0% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.